Home/Certificate Archive/A26Q2GLW0104
Alpha NordiskDanish Formulation Technology

Certificate of Analysis

Accession No.COA-A26Q2GLW0104
ClientAlpha Nordisk
Report Date6/9/2026
ProductGLOWLotA26Q2GLW0104
ChemicalGHK-Cu · TB-500 · BPC-157 blendMfg Date2026-Q2
FormLyophilized PowderExp DateEXP 05/28
Dose70mgPurity99.2%
FormulaBlendNet Content68.9 mg
Mol. Weight403.9 DaAppearanceWhite lyophilized powder
All chemical analysis performed in accordance with European Pharmacopoeia (Ph. Eur.) reference methods — HPLC-UV (C18, 220 nm) for purity; ESI-MS (≤5 ppm) for identity confirmation
TestMethodSpecificationResultStatus
AppearanceVisual inspectionWhite lyophilized powderConforms✓ PASS
IdentityESI-MS (≤5 ppm)Confirmed [M+H]⁺ = 404.9Confirmed✓ PASS
PurityHPLC-UV (C18, 220 nm)≥99.0%99.2%✓ PASS
Related substancesHPLC-UV≤1.0% total<0.8%✓ PASS
EndotoxinLAL (gel-clot)<1.0 EU/mg<0.5 EU/mg✓ PASS
Water contentKarl Fischer<8.0%<5.2%✓ PASS
CounterionIon chromatographyAcetate (TFA-free)Acetate✓ PASS
SterilityUSP <71> visualNo visible contaminationConforms✓ PASS

HPLC-UV Chromatogram (220 nm)

024681012140100200300400500600mAUTime (min)GLOW | 99.2%tR = 9.1 minλ = 220 nm | C18 | TFA/ACN gradient

* Representative chromatogram shown for GHK-Cu (dominant component)

ESI Mass Spectrum

Identity confirmed by componentamino acid profile analysisESI-MS (individual components confirmed)
Alpha Nordiskalphanordisk.com/verifyalphanordisk.com/methodology — Analytical methodology standardVerify this certificate at alphanordisk.com/verify/A26Q2GLW0104
A26Q2GLW0104Danish Formulation Technology

This Certificate of Analysis is issued by Alpha Nordisk for research and laboratory use documentation. The peptide described is intended exclusively for research and laboratory use. Not for human consumption, clinical, diagnostic, or therapeutic application. Lot traceability and analytical data are maintained by Alpha Nordisk under Danish Formulation Technology standards.